Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals
An. bras. dermatol; 96 (4), 2021
Results: 14
Urticaria multiforme: a case report in an infant
An. bras. dermatol; 94 (5), 2019
Biopsia, Diagnóstico Diferencial, Eritema/diagnóstico, Eritema/patología, Eritema Multiforme/diagnóstico, Eritema Multiforme/patología, Antagonistas de los Receptores Histamínicos H1/uso terapéutico, Hidroxizina/uso terapéutico, Enfermedades Cutáneas Genéticas/diagnóstico, Enfermedades Cutáneas Genéticas/patología, Urticaria/diagnóstico, Urticaria/tratamiento farmacológico, Urticaria/patología
Incapacitating solar urticaria: successful treatment with omalizumab
An. bras. dermatol; 94 (3), 2019
Abstract: Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontan...
Antialérgicos/uso terapéutico, Omalizumab/uso terapéutico, Trastornos por Fotosensibilidad/diagnóstico, Trastornos por Fotosensibilidad/tratamiento farmacológico, Trastornos por Fotosensibilidad/etiología, Luz Solar/efectos adversos, Urticaria/diagnóstico, Urticaria/tratamiento farmacológico, Urticaria/etiología
Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology
An. bras. dermatol; 94 (2,supl.1), 2019
Abstract: Background: Urticarias are frequent diseases, with 15% to 20% of the population presenting at least one acute episode in their lifetime. Urticaria are classified in acute ( ≤ 6 weeks) or chronic (> 6 weeks). They may be induced or spontaneous. Objectives: To verify the diagnostic and...
Antialérgicos/uso terapéutico, Brasil, Enfermedad Crónica, Consenso, Ciclosporinas/uso terapéutico, Dermatología, Antagonistas de los Receptores Histamínicos H1 no Sedantes/uso terapéutico, Inmunosupresores/uso terapéutico, Omalizumab/uso terapéutico, Índice de Severidad de la Enfermedad, Sociedades Médicas, Urticaria/diagnóstico, Urticaria/tratamiento farmacológico, Urticaria/prevención & control
Guía clínica chilena de urticaria crónica espontánea
Rev. méd. Chile; 146 (11), 2018
Chronic urticaria (CU) is characterized by itchy wheals, angioedema or both lasting six weeks or more. It is classified as spontaneous (CSU) and inducible urticaria (CIndU), depending whether there is an identifiable trigger or not. CSU is the predominant form, affecting more than 75% of patients, althou...
Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria
An. bras. dermatol; 92 (3), 2017
Abstract Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total cumulative dose 195mg). Our study highlig...
Fármacos Dermatológicos/efectos adversos, Metotrexato/efectos adversos, Pneumocystis carinii, Neumonía por Pneumocystis/inducido químicamente, Enfermedad Crónica, Fármacos Dermatológicos/administración & dosificación, Metotrexato/administración & dosificación, Neumonía por Pneumocystis/diagnóstico por imagen, Tomografía Computarizada por Rayos X, Urticaria/tratamiento farmacológico
Allergic reaction to patent blue dye in breast surgery - case report
Rev. bras. anestesiol; 66 (4), 2016
Abstract We present a case of allergic reaction to patent blue in a patient who underwent excision of sentinel lymph node associated with segmental breast resection. About 20 min after the dye injection, the patient developed hypotension (BP = 70 × 30 mmHg) associated with increased heart frequency. The...
Antiinflamatorios/uso terapéutico, Mama/cirugía, Colorantes/efectos adversos, Hipersensibilidad a las Drogas/complicaciones, Hipersensibilidad a las Drogas/diagnóstico, Hipersensibilidad a las Drogas/tratamiento farmacológico, Hidrocortisona/uso terapéutico, Persona de Mediana Edad, Colorantes de Rosanilina/efectos adversos, Urticaria/complicaciones, Urticaria/tratamiento farmacológico
Guía argentina de urticaria y angioedema
Argentine guidelines for urticaria and angioedema
Medicina (B.Aires); 74 Suppl 1 (), 2014
This interdisciplinary paper summarizes the news in the diagnosis and treatment of chronic urticaria (CU), and provides concepts, definitions and evidence-based suggestions for its management. Urticaria occurs in at least 20...
Algoritmos, Angioedema/tratamiento farmacológico, Antialérgicos/uso terapéutico, Argentina, Enfermedad Crónica, Ensayos Clínicos como Asunto, Antagonistas de los Receptores Histamínicos/uso terapéutico, Urticaria/diagnóstico, Urticaria/tratamiento farmacológico, Urticaria/etiología, Urticaria/fisiopatología, Calidad de Vida, Omalizumab, Diagnóstico Diferencial
Estudo duplo-cego entre astemizol e terfenadina no tratamento da urticária crônica
Astemizol and terfenadine: double-blind study in the treatment of chronic urticaria
Folha med; 99 (5/6), 1989
Foram estudados 40 pacientes portadores de urticária crônica, que receberam, durante quatro semanas, 10 mg de astemizol ou 120 mg de terfenadina ao dia, seguindo-se um modelo duplo-cego randomizado. Os resultados mostraram ser o astemizol täo eficaz e bem tolerado quanto a terfenadina, sendo também s...